| # | Drug | Count |
|---|---|---|
| 0 | FLUOXETINE HYDROCHLORIDE | 14 |
| 1 | LAMOTRIGINE | 14 |
| 2 | NEBIVOLOL | 11 |
| 3 | NEBIVOLOL HYDROCHLORIDE | 11 |
| 4 | LAMOTIRIGINE | 10 |
| 5 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 10 |
| 6 | LAMOTRIGINE EXTENDED-RELEASE | 10 |
| 7 | TRIMIPRAMINE | 10 |
| 8 | BUPRENORPHINE | 8 |
| 9 | FLUOXETINE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIMIPRAMINE | 10 | 0.0091 |
| 1 | NEBIVOLOL HYDROCHLORIDE | 11 | 0.0003 |
| 2 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 3 | LAMOTIRIGINE | 10 | 0.0001 |
| 4 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 10 | 0.0001 |
| 5 | FLUOXETINE HYDROCHLORIDE | 14 | 0.0001 |
| 6 | LAMOTRIGINE | 14 | 0.0001 |
| 7 | OLANZAPINE | 7 | 0.0001 |
| 8 | GLECAPREVIR AND PIBRENTASVIR | 1 | 0.0001 |
| 9 | BUPRENORPHINE | 8 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 14 |
| 1 | Mood Stabilizer [EPC] | 14 |
| 2 | Benzodiazepine [EPC] | 11 |
| 3 | beta-Adrenergic Blocker [EPC] | 11 |
| 4 | Partial Opioid Agonist [EPC] | 8 |
| 5 | Atypical Antipsychotic [EPC] | 7 |
| 6 | Interferon beta [EPC] | 2 |
| 7 | Androgen Receptor Inhibitor [EPC] | 1 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 1 |
| 9 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 8 | 0.0001 |
| 1 | Mood Stabilizer [EPC] | 14 | 0.0001 |
| 2 | Anti-epileptic Agent [EPC] | 14 | 0.0001 |
| 3 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 4 | beta-Adrenergic Blocker [EPC] | 11 | 0.0000 |
| 5 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Benzodiazepine [EPC] | 11 | 0.0000 |
| 7 | Atypical Antipsychotic [EPC] | 7 | 0.0000 |
| 8 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Interferon beta [EPC] | 2 | 0.0000 |